Type 1 Diabetes Clinical Trial
Official title:
Diabetes Distress,Psychological Well-being and Family Hardiness in Parents of Children and Adolescents With Type 1 Diabetes
Verified date | February 2014 |
Source | University Medical Centre Ljubljana |
Contact | n/a |
Is FDA regulated | No |
Health authority | Slovenia: Ministry of Health |
Study type | Observational |
Parents have an important role in child's diabetes management. Many studies show that
parental psychological stress and family dynamics are associated with parental
diabetes-related distress and treatment outcomes among children and adolescents with type 1
diabetes.
The aim of this study is to analyze diabetes distress (diabetes-related parenting burden and
fear of hypoglycemia), parental psychological well-being (anxiety, satisfaction with life,
positive and negative affect and adult attachment relationship pattern), family hardiness
and characteristics of children with type 1 diabetes in a sample of mothers and fathers of
children and adolescents with type 1 diabetes of ages up to 18 years.
In this study it is hypothesized that:
1. greater parental fear of hypoglycemia and diabetes-related burden are associated with
lower family hardiness and worse psychological well-being parents and higher HbA1c
levels in children and adolescents with type 1 diabetes;
2. mothers will report greater fear of hypoglycemia, diabetes-related burden and lower
psychological well-being comparing to fathers.
3. parents of children and adolescents with type 1diabetes will report greater anxiety,
lower psychological well-being and family hardiness comparing to parents of children
without diabetes.
Standardized and validated questionnaires will be used to determine: parental fear of
hypoglycemia, diabetes-related burden, parent level of anxiety, psychological well-being,
adult attachment relationship pattern and family hardiness.
The investigators will also measure parent daily involvement in child's diabetes management,
frequency of blood glucose monitoring and parent general satisfaction with glycemic control.
Objective measures such as child's HbA1c level and experience of severe hypoglycemia episode
will also be obtained. These measures will be correlated with other research variables.
Status | Completed |
Enrollment | 300 |
Est. completion date | February 2014 |
Est. primary completion date | February 2014 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 2 Years to 18 Years |
Eligibility |
Inclusion Criteria: - Parents or caregivers of children and adolescents with T1D of ages up to 18 years - Minimal 1 year duration of Type 1 diabetes Exclusion Criteria: - Parents or caregivers of children and adolescents with T1D of ages over 18 years |
Observational Model: Case Control, Time Perspective: Cross-Sectional
Country | Name | City | State |
---|---|---|---|
Slovenia | Dept. of Pediatric Endocrinology, Diabetes & Metabolism, University Children's Hospital, UMCL | Ljubljana |
Lead Sponsor | Collaborator |
---|---|
University Medical Centre Ljubljana | Slovenian Research Agency (ARRS) |
Slovenia,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | family hardiness | FHI (Family Hardiness Index) | 1 month | No |
Other | objective measures | parent daily involvement in child's diabetes management frequency of blood glucose monitoring parent general satisfaction with glycemic control child's HbA1c level child's experience of severe hypoglycemia |
1 month | No |
Primary | parental diabetes-related distress | To examine associations between diabetes-related distress - diabetes burden (Problem Areas In Diabetes-Parent (PAID-P) questionnaire), fear of hypoglycemia (Hypoglycemia Fear Survey-Parent (HFS-P) questionnaire, Hypoglycemia Fear Survey- Parents of Young Children (HFS-PYC) questionnaire) | 1 month | No |
Secondary | psychosocial characteristics | STAIX (State Trait Anxiety Inventory), PANAS (The Positive And Negative Affect Schedule), SWLS (Satisfaction With Life Scale), RQ (Relationship Questionnaire) | 1 month | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05653518 -
Artificial Pancreas Technology to Reduce Glycemic Variability and Improve Cardiovascular Health in Type 1 Diabetes
|
N/A | |
Enrolling by invitation |
NCT05515939 -
Evaluating the InPen in Pediatric Type 1 Diabetes
|
||
Completed |
NCT05109520 -
Evaluation of Glycemic Control and Quality of Life in Adults With Type 1 Diabetes During Continuous Glucose Monitoring When Switching to Insulin Glargine 300 U/mL
|
||
Recruiting |
NCT04016987 -
Automated Structured Education Based on an App and AI in Chinese Patients With Type 1 Diabetes
|
N/A | |
Active, not recruiting |
NCT04190368 -
Team Clinic: Virtual Expansion of an Innovative Multi-Disciplinary Care Model for Adolescents and Young Adults With Type 1 Diabetes
|
N/A | |
Recruiting |
NCT05413005 -
Efficacy of Extracorporeal Photopheresis (ECP) in the Treatment of Type 1 Diabetes Mellitus
|
Early Phase 1 | |
Active, not recruiting |
NCT04668612 -
Dual-wave Boluses in Children With Type 1 Diabetes Insulin Boluses in Children With Type 1 Diabetes
|
N/A | |
Completed |
NCT02837094 -
Enhanced Epidermal Antigen Specific Immunotherapy Trial -1
|
Phase 1 | |
Recruiting |
NCT05414409 -
The Gut Microbiome in Type 1 Diabetes and Mechanism of Metformin Action
|
Phase 2 | |
Recruiting |
NCT05670366 -
The Integration of Physical Activity Into the Clinical Decision Process of People With Type 1 Diabetes
|
N/A | |
Active, not recruiting |
NCT05418699 -
Real-life Data From Diabetic Patients on Closed-loop Pumps
|
||
Completed |
NCT04084171 -
Safety of Artificial Pancreas Therapy in Preschoolers, Age 2-6
|
N/A | |
Recruiting |
NCT06144554 -
Post Market Registry for the Omnipod 5 System in Children and Adults With Type 1 Diabetes
|
||
Recruiting |
NCT05379686 -
Low-Dose Glucagon and Advanced Hybrid Closed-Loop System for Prevention of Exercise-Induced Hypoglycaemia in People With Type 1 Diabetes
|
N/A | |
Recruiting |
NCT05153070 -
Ciclosporin Followed by Low-dose IL-2 in Patients With Recently Diagnosed Type 1 Diabetes
|
Phase 2 | |
Completed |
NCT05281614 -
Immune Effects of Vedolizumab With or Without Anti-TNF Pre-treatment in T1D
|
Early Phase 1 | |
Withdrawn |
NCT04259775 -
Guided User-initiated Insulin Dose Enhancements (GUIDE) to Improve Outcomes for Youth With Type 1 Diabetes
|
N/A | |
Active, not recruiting |
NCT01600924 -
Study on the Assessment of Determinants of Muscle and Bone Strength Abnormalities in Diabetes
|
||
Completed |
NCT02897557 -
Insulet Artificial Pancreas Early Feasibility Study
|
N/A | |
Completed |
NCT02914886 -
Beneficial Effect of Insulin Glulisine by Lipoatrophy and Type 1 Diabetes (LAS)
|
Phase 4 |